Marcelo Sal Email & Phone Number

Argentina

Greater Buenos Aires, Argentina

-Be responsible for developing and implementing market access and policy strategies to ensure the successful launch and growth of the Rare Diseases portfolio across Argentina. Ensure market access strategies are aligned with corporate and commercial strategies, including positioning, country sequencing, price corridors, price volume tradeoffs, and corporate stance on topics such as market entry, reference pricing and managed access programs.-Represent the company in key meetings with HMOs… Show more -Be responsible for developing and implementing market access and policy strategies to ensure the successful launch and growth of the Rare Diseases portfolio across Argentina. Ensure market access strategies are aligned with corporate and commercial strategies, including positioning, country sequencing, price corridors, price volume tradeoffs, and corporate stance on topics such as market entry, reference pricing and managed access programs.-Represent the company in key meetings with HMOs and reimbursement agencies in the country, including negotiations at the country level.-Lead key country policy initiatives including presence at selected conferences, developing long-term trusting partnerships with key groups, key industry associations, and key driving policy-shaping policy efforts to enable access to gene therapies-Proactively identify targeted opportunities with payers, policymakers and other stakeholders to enable access and reimbursement for gene therapies and for rare diseases. Show less

Argentina

Launching Biosimilar local products, Interferon Beta-1a 30mcg, FSH, GH, Erythropoietin, GSG-F and Etanercept focused on hematology, oncology, nephrology, multiple sclerosis, rheumatology, growth hormone and fertility. Directing the development of the annual commercial and marketing plan, specifically providing forecast about each product in its territory.Dealing with the field force, having a strong relationship with the KOLs of all different specialties and the related local… Show more Launching Biosimilar local products, Interferon Beta-1a 30mcg, FSH, GH, Erythropoietin, GSG-F and Etanercept focused on hematology, oncology, nephrology, multiple sclerosis, rheumatology, growth hormone and fertility. Directing the development of the annual commercial and marketing plan, specifically providing forecast about each product in its territory.Dealing with the field force, having a strong relationship with the KOLs of all different specialties and the related local Medical Societies. Show less

Argentina

Start-up for a rare metabolic disease Business: Hypophosphatasia.Launched Strensiq, a specific enzyme, for Hypophosphatasia. Determined annual plans and implemented marketing strategies. Analyzed trends and results and projected unpredictable sales due to the rareness of the disease.Having been strong, caring, professional relationship with Regional Pediatric Endocrinology Societies; attending educational workshops, reviewing medical publications, establishing one-to-one… Show more Start-up for a rare metabolic disease Business: Hypophosphatasia.Launched Strensiq, a specific enzyme, for Hypophosphatasia. Determined annual plans and implemented marketing strategies. Analyzed trends and results and projected unpredictable sales due to the rareness of the disease.Having been strong, caring, professional relationship with Regional Pediatric Endocrinology Societies; attending educational workshops, reviewing medical publications, establishing one-to-one networks, working with physicians and genetic lab partners. Show less

Argentina

Managed marketing, sales and commercial strategies for Biosimilar´s products: Blastoferon (Interferon beta-1a), HHT (Growth Hormone), Hemax (Erythropoietin) and Neutromax (GSG-F) which is related to hematology, oncology, multiple sclerosis, nephrology, pediatric endocrinology, virology and rare diseases.Commercial Manager (regional Latin-American experience) in Delta Farma (a branch of Sidus company specialized in chemotherapy and HIV products). Outstanding ability to foster joint… Show more Managed marketing, sales and commercial strategies for Biosimilar´s products: Blastoferon (Interferon beta-1a), HHT (Growth Hormone), Hemax (Erythropoietin) and Neutromax (GSG-F) which is related to hematology, oncology, multiple sclerosis, nephrology, pediatric endocrinology, virology and rare diseases.Commercial Manager (regional Latin-American experience) in Delta Farma (a branch of Sidus company specialized in chemotherapy and HIV products). Outstanding ability to foster joint ventures with pharmaceutical companies and distributors in Chile, Brazil, Ecuador, Panamá, Costa Rica, Guatemala and Dominican Republic. In charge of Chemotherapy Subsidiary in Sidus Uruguay and Sidus Paraguay. Show less

Argentina

Developed a National Marketing and sales Strategies for:• Oncology: Breast and lung cancer.• Hospital Products line: Anti-infective, analgesics and anesthetics.• Urology: Prostate cancerLaunched the first M+ EGFR platform for lung cancer Iressa (Gefitinib).Having been the Head of marketing, sales, access and commercial managers. In charge of Rontag Oncology (Chemotherapy generics division).

Argentina

Carried out effective research for Oncology, Urology and Hematology markets and other trends.Planned and implemented marketing activities for: • Oncology: kidney, hepatocellular and prostate cancer.• Hematology: Chronic lymphatic leukemia and Non Hodgkin lymphoma.• Urology: Prostate cancer.• HPP: Primary Pulmonary Hypertension Developed the oral Fludara (Fludarabine) market in hematology.Building up the strategies of Campath (Alemtuzumab) in chronic… Show more Carried out effective research for Oncology, Urology and Hematology markets and other trends.Planned and implemented marketing activities for: • Oncology: kidney, hepatocellular and prostate cancer.• Hematology: Chronic lymphatic leukemia and Non Hodgkin lymphoma.• Urology: Prostate cancer.• HPP: Primary Pulmonary Hypertension Developed the oral Fludara (Fludarabine) market in hematology.Building up the strategies of Campath (Alemtuzumab) in chronic lymphocytic leukemiaLaunched Nexavar (Sorafenib) for kidney cancer and hepatocellular carcinoma. Implemented the radioinmunotherapy with Zevamab (Ibritumomab tiuxetan).Having been Betaseron (Interferon Beta-1b) and Pulmonary Hypertension (Ventavis) sales representative. Show less

Argentina

Argentina

Post Grado, Direccion Comercial

Licentiate Degree, Marketing

Bachelor Of Pharmacy - Bpharm, Pharmacy, Incomplete

Diplomatura En Economía De La Salud, Business